Infertility Treatment Devices And Equipment Market To Reach $555.2Mn By 2030

Infertility Treatment Devices And Equipment Market Growth & Trends

The global infertility treatment devices and equipment market size is expected to reach USD 555.2 million by 2030, according to a new report by Grand View Research, Inc.It is projected to expand at a CAGR of 10.56% over the forecast period. The key factors driving the market growth include an increase in the prevalence of infertility in both sexes, as well as the rapid growth of government-funded fertility clinics and infertility treatments, high adoption of Assisted Reproductive Technology (ART), and an increase in the number of fertility clinics year over year.

High adoption of Assisted Reproductive Technology (ART) is a significant driver in the market for infertility treatment devices & equipment. The increasing awareness and acceptance of ART is a major factor that has led to a surge in demand for these procedures. According to a report by the Centers for Disease Control and Prevention (CDC), the use of ART has doubled in the past decade in the U.S. alone.

The number of medical centers providing infertility treatment has increased over the past few years due to an increase in the prevalence of infertility cases around the world. Intensive treatments, such as IVF and insemination, are performed in fertility clinics. These clinics also perform sperm washing, a process to prepare a sperm sample for insemination by eliminating impurities from the semen, which helps increase the chances of conception. Patients can receive counseling in specialized fertility clinics.

 Request a free sample copy or view report summary: Infertility Treatment Devices And Equipment Market Report

Infertility Treatment Devices And Equipment Market Report Highlights

• Sperm separation devices held the largest market share of approximately 18% in the type segment in 2022. Sperm separation devices are used in most ART treatments, such as IVF and artificial insemination

• Fertility clinics led the end-use segment with a dominant revenue share in 2022 and this segment is expected to witness the fastest CAGR of 11.20% during the forecast period. Fertility clinics offer specialized treatments, completely focusing on infertility issues, as compared to hospitals

• Europe held the leading regional share of almost 40% in 2022, as the fertility rate in the region has been decreasing over the years. Delays in pregnancy and lifestyle changes are among the factors contributing to this decline

• The demand for ART treatments is expected to grow exponentially in Asia Pacific, owing to the rise of fertility tourism, an increase in the number of international players focusing on entering the market in economically developing countries, and changing regulatory landscape

Infertility Treatment Devices And Equipment Market Segmentation

Grand View Research has segmented the global infertility treatment devices and equipment market based on type, end-use, and region:

Infertility Treatment Devices & Equipment Type Outlook (Revenue, USD Million, 2018 - 2030)

• Ovum Aspiration Pumps

• Sperm Separation Device

• Sperm Analyzer Systems

• Micromanipulators Systems

• Incubators

• Cryosystems

• Imaging System

• Microscopes

• Others

Infertility Treatment Devices & Equipment End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Fertility Clinics

• Hospitals & Other Healthcare Facilities

• Clinical Research Institutes

Infertility Treatment Devices & Equipment Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Norway

  • Sweden

• Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

  • Colombia

• Middle East & Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Infertility Treatment Devices And Equipment Market

• The Cooper Companies Inc.

• Cook Medical

• Vitrolife

• DxNow

• Eppendorf AG

• AB Scientific Ltd.

• Hamilton Thorne, Inc.

• IVFtech ApS

• Rocket Medical Plc.

• Art Biotech Pvt. Ltd.

• LabIVF Asia Pte Ltd.

• Esco Micro Pte. Ltd.